Ipsen SA
IPN.PA- Latest Trade
- trading lower95.4EUR
- Change
- -0.9
- % Change
0.93%Negative
- Day Range
- 95.05 - 97.00
- 52-Week Range
- 77.00 - 121.00
As of May 28 2022. Values delayed up to 15 minutes
- Previous Close
- 96.30
- Open
- 96.40
- Volume
- 56,877.00
- 3 Month Average Trading Volume
- 2.37
- Shares Out (Mil)
- 82.65
- Market Cap
- 8,071.34
- Forward P/E
- 10.83
- Dividend Yield
- 1.25
Key Statistics
2.9 mean rating - 20 analysts
- P/E Excl. Extra Items (TTM)
- 12.42
- Price To Sales (TTM)
- 2.69
- Price To Book (Quarterly)
- 2.89
- Price To Cash Flow (Per Share TTM)
- 9.14
- Total Debt/Total Equity (Quarterly)
- 25.19
- Long Term Debt/Equity (Quarterly)
- 23.91
- Return On Investment (TTM)
- 18.81
- Return On Equity (TTM)
- 13.87
2021 (millions USD)
About Ipsen SA
Company Information
Ipsen SA is a France-based biopharmaceutical group specialized in specialty care. The Company operates globally through two segments: Specialty Care and Consumer Healthcare. In Specialty Care, the Company is focused on various therapeutic areas, including oncology, neurosciences and rare diseases. Its oncology portfolio includes Somatuline, Decapeptyl, Cabometyx and Onivyde. Its neuroscience portfolio includes Dysport, and in rare diseases key products are NutropinAq and Increlex. Its primary care portfolio includes Smecta, Forlax, Fortrans, Eziclen, and Tanakan. In oncology Ipsen focuses on a number of disease areas, which include neuroendocrine tumors, renal cell carcinoma, hepatocellular carcinoma and pancreatic cancer. In addition, the Company has specialism in neurotoxin research and operates three research and development centers located in France, the United Kingdom and the United States.
Address
65 Quai Georges GorseBOULOGNE-BILLANCOURT,
92100
France
Industry
Biotechnology & Drugs
Executive Leadership
- Marc de Garidel
- Chairman of the Board
- David Loew
- Chief Executive Officer, Director
- Antoine Flochel
- Vice Chairman of the Board
- Aymeric le Chatelier
- Chief Financial Officer, Executive Vice President
- Regis Mulot
- Chief Human Resource Officer, Executive Vice President
- Dominique Laymand
- Executive Vice President, Chief Ethics and Compliance Officer
- Francois Henri Louis Garnier
- Executive Vice President, General Counsel
- Dominique Bery
- Executive Vice President, Strategy and Transformation
- Stewart Campbell
- Executive Vice President and President of North America
- Benoit Hennion
- Executive Vice President and President, Consumer Healthcare
- Steven Hildemann
- Executive Vice President, Chief Medical Officer
- Philippe Lopes-Fernandes
- Executive Vice President, Chief Business Officer
- Howard Mayer
- Executive Vice President, Head of Research & Development
- Aidan Murphy
- Executive Vice-President, Technical Operations
- Richard A. Paulson
- Executive Vice President and Chief Executive Officer of Ipsen North America
- Mari Scheiffele
- Executive Vice President, President, Specialty Care International
- Gwenan White
- Executive Vice President, Communications and Public Affairs
- Anne Beaufour
- Director, Permanent representative of Highrock S.àr.l.
- Henri Beaufour
- Director
- Philippe Bonhomme
- Director, Permanent representative of Beech Tree SA
- Laetitia Ducroquet
- Director, Representing Employees
- Michele Ollier
- Director
- Jean-Marc Parant
- Director, representing Employees
- Carol Xueref
- Director
- Margaret Liu
- Independent Director
- Paul Jai Sekhri
- Independent Director
- Carol Stuckley
- Independent Director
- Piet Wigerinck
- Independent Director
- Karen Witts
- Independent Director
Latest News
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,850.60 | 0.16%Positive |
| Copper | 776.75 | 0.69%Positive |
| Brent Crude Oil | 119.43 | -- |
| CBOT Soybeans | 1,732.50 | 0.35%Positive |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 4,158.24 | 2.47%Positive |
| Euro STOXX 50 | 3,808.86 | 1.83%Positive |
| FTSE 100 | 7,585.46 | 0.27%Positive |
| Nikkei 225 | 26,781.68 | 0.66%Positive |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes